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Abstract
Objective: To assess the efficacy of the D-R model for defining trends in the appearance of Ceftazidime-resistant Escherichia
coli.
Methods: Actual data related to the manifestation of Ceftazidime-resistant E. coli spanning years 1996–2009 were collected
from the China National Knowledge Internet. These data originated from 430 publications encompassing 1004 citations of
resistance. The GM(1,1) and the novel D-R models were used to fit current data and from this, predict trends in the
appearance of the drug-resistant phenotype. The results were evaluated by Relative Standard Error (RSE), Mean Absolute
Deviation (MAD) and Mean Absolute Error (MAE).
Results: Results from the D-R model showed a rapid increase in the appearance of Ceftazidime-resistant E. coli in this region
of the world. These results were considered accurate based upon the minor values calculated for RSE, MAD and MAE, and
were equivalent to or better than those generated by the GM(1,1) model.
Conclusion: The D-R model which was originally created to define trends in the transmission of swine viral diseases can be
adapted to evaluating trends in the appearance of Ceftazidime-resistant E. coli. Using only a limited amount of data to
initiate the study, our predictions closely mirrored the changes in drug resistance rates which showed a steady increase
through 2005, a decrease between 2005 and 2008, and a dramatic inflection point and abrupt increase beginning in 2008.
This is consistent with a resistance profile where changes in drug intervention temporarily delayed the upward trend in the
appearance of the resistant phenotype; however, resistance quickly resumed its upward momentum in 2008 and this
change was better predicted using the D-R model. Additional work is needed to determine if this pattern of ‘‘increase-
control-increase’’ is indicative of Ceftazidime-resistant E. coli or can be generally ascribed to bacteria acquiring resistance to
drugs in the absence of alternative intervention.
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Introduction
Escherichia coli is a Gram negative rod-shaped bacterium that is
commonly found in the lower intestine of warm-blooded
organisms. Although most E. coli strains are harmless, some such
as serotype O157:H7, can cause serious food poisoning in humans
[1,2]. Symbiotic strains are part of the normal flora of the gut and
can benefit their hosts by producing vitamin K2 [3], and by
preventing pathogenic bacteria from establishing within the
intestine [4,5].
Harmful bacterial infections are usually treated with antibiotics.
In contrast to Gram-positive organisms, resistance to antibiotics is
more likely found among strains of E. coli. Ceftazidime is a third-
generation cephalosporin antibiotic which has broad spectrum
activity against both Gram-positive and Gram-negative bacteria;
however, it is less effective in ridding Gram-positive microorgan-
isms and therefore used mostly to treat Gram-negative infections
in China.
Antibiotic resistance is a growing problem due to overuse in
humans and in some cases overuse in the feed given to animals as a
means to promote growth and weight gain [6]. This is particularly
true for Ceftazidime in China. Evaluation of the appearance of
Ceftazidime-resistant E. coli may provide guidance on the
appropriate clinical use of this and other antibiotics. Herein, we
used a novel algorithm, the D-R model and compared this to
another algorithm, the Grey Model, GM(1,1), to simulate the
resistance to Ceftazidime and to predict future trend lines for the
appearance of this phenotype. In our studies, the D-R model
showed fit and forecasting characteristics that equaled or bettered
those generated by the GM(1,1) model. Importantly, the resistance
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e27295of E. coli to this drug showed a pseudobiphasic response where a
period of stable or decreasing resistance was followed by an abrupt
increase or reemergence of the phenotype. These data and the D-
R algorithm may provide useful and more general references for
controlled application of antibiotics clinically.
Materials and Methods
Data collection
Data on Ceftazidime-resistant E. coli in China between 1996
and 2009 were collected from the China National Knowledge
Internet (CNKI). The keywords for the search included E. coli,
Ceftazidime and/or drug resistance. Generally, the data were
derived from hospitals and institutes of more than thirty provinces.
The rules for data collection were as follows: 1) recorded drug
resistance was restricted to E. coli; 2) Ceftazidime-resistance rates
in E. coli were to be from literature sources only; 3) data sets had to
be defined by resistant strain number and statistical year, and; 4)
data had to pass manual verification as not being duplicated within
the data set. If collected resistance data extended over consecutive
years, these data were partitioned equally among the years
spanned. The total number of reports of drug-resistant E. coli per
year/total number of reports of E. coli infections per year=nor-
malized annual drug-resistance rate. The statistical analysis was
performed by trend x2 test using SPSS13.0 software.
Calculations and model fitting
Time series prediction is the process by which future values of a
system can be forecast based on past and current data points. If all
the information about a system is available, it is considered a White
system. If no information exists, it is a Black system. Those systems
described by limited available data are by definition Grey systems.
One of the most common algorithms used today for forecasting
future trends is the GM(1,1) model from grey system theory [7]
which requires only a few historical and current data points to
estimatethefuture behaviorofanunknownsystem.Based upon grey
system theory and the GM(1,1) model, the D-R model [8] was first
developed to predict future trends in H1N1 cases in mainland
China. The D-R model gives less consideration to micro-
environmental factors. It establishes upper and lower limits of the
prediction intervals and accounts for dominating long or short term
effects by incorporating self-adapting parameters into the equation.
Comparingthe twomodels,wefound that theD-Rmodel hadbetter
predictive value than the GM(1,1) model for the H1N1 data set.
We decided to expand the usability of the D-R model and test
its predictive value on forecasting the spread of Ceftazidime-
resistant E. coli. As such, the D-R and GM(1,1) models were used
to calculate the Ceftazidime-resistance rates of E. coli extending
from 1996 to 2009 in China. Comparisons between the actual
values and calculated values were analyzed using the Relative
standard error (RSE), Mean absolute deviation (MAD) and Mean Absolute
Error (MAE) to test the accuracy of the fit. These relationships are
defined by the equations below (10):
RSE~
X
At{Ft ðÞ
2
  
= n{1 ðÞ
hi 1=2
;
MAD~
X
At{Ft ðÞ jj =n; MAE~
X
At{Ft jj =At
   hi
=n
Where At=the actual drug resistance data; Ft=fitted or calculated
drug resistance data; and n=sample number.
Future predictions in drug resistance
Once the best model was identified, the actual Ceftazidime-
resistance rates for E. coli between 1996 and 2009 in China were
used to predict future Ceftazidime-resistance rates for E. coli
between 2009 and 2012 using that model. The forecasting abilities
of the D-R model were compared to those generated by the
GM(1,1) model. Also, in order to assess the importance of
incorporating current data and the ability of the D-R model to
adapt to inflections points in the data, we evaluated the predictive
character of the D-R model using information from four different
time frames; 1996–1998, 1996–2000, 1996–2004 and 1996–2008.
These time frames were chosen because each preceded mini peaks
in the actual drug-resistance rates found in 1997, 2000, 2004 and
2008.
Results
Statistical analysis
Analysis was performed on 1004 pieces of data defining
Ceftazidime-resistance rates in E.coli The normalized drug-
resistance rate/year evaluated by x
2 test ((trendx
2 test)) had a
p,0.01 indicating that the Ceftazidime-resistance rates for E. coli
significantly increased during the period 1996–2009.
Fitting of D-R and GM(1,1) models
The relationship between the actual Ceftazidime-resistance
rates for E. coli and the predicted values were analyzed with D-R
and GM(1,1) models (Figure 1; Table 1). Based on the calculated
data and the actual data, the RSE, MAD and MAE values were
determined and summarized in Table 2. The values based on the
D-R algorithm were noticeably more in line with the actual data
Figure 1. Observed and predicted rates of E. coli resistance to Ceftazidime using the D-R and GM(1,1) models. At=actual data; D-
R=rates forecasted using the D-R model; Upper and Lower=the limits of the D-R model; GM(1.1)=rates forecasted using the GM model.
doi:10.1371/journal.pone.0027295.g001
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algorithm was as good as if not better than the GM(1,1) model for
predicting changes to the trend line of E. coli resistance to
Ceftazidime.
Forecasting future rates of E. coli Ceftazidime-resistance
using the D-R model
Based upon calculations of Ceftazidime-resistance rates between
1996 and 2009 using the D-R model, the Ceftazidime-resistance
ratesfor2010,2011and 2012wereprojectedtobe63.20%,76.56%
and 90.08%, respectively (Table 3, Figure 2), provided there are no
changes in drug intervention. However, using any other time
intervals to predict future trends i.e. 1996–1998, 1996–2000, and
1996–2004, the results showed no appreciable changes in the rates
beyond 20% inasmuch as none of these included the recent
inflection point observed in the years 2007–2008. This difference in
predictive value reflects the importance of recent data in forecasting
and the ability of the D-R model to better incorporate these types of
inflection points than the GM(1,1) model.
Discussion
In China, Ceftazidime is among the most commonly prescribed
antibiotics for treating E. coli infections. Unfortunately, its misuse
and overuse has resulted in Ceftazidime-resistant organisms.
Surveillance for the drug-resistant phenotype is therefore impor-
tant and can be an effective method for controlling the escalation
and spread of these bacteria.
Accuracy indices defined by RSE, MAD and MAE are
extensively used when fitting data, where smaller values are
indicative of more accurate associations between calculated data
sets [8–10]. In this study, the RSE, MAD, ARE values using the
D-R model coincided well with actual values indicating the
potential use of this model for predictive purposes. Upon
examination of the actual data, we found that the drug-resistance
rates generally increased between 1996 and 2005 after which they
slightly decreased then resumed an upward trend but at a faster
rate beginning in 2008. Four mini peaks were found in 1997,
2000, 2004 and 2008. Coinciding with each peak year, literature
citations were found which argued the importance of decreasing
the rate of drug application as a means to control resistance. This
relationship is circumstantial at best; however, Ceftazidime-
resistance always seemed to increase at a later point in time and
after the cautionary notes on attenuating usage waned.
Using the D-R model and based on the data obtained between
1996–1998, 1996–2000, 1996–2004 and 1996–2008, we predicted
the future trends between 1999–2012, 2001–2012, 2005–2012 and
2009–2012, respectively (Table 3, Figure 2). From Figure 2, we
can see that before 2008, had constrained drug treatment or
combination drug therapy been used, the drug resistance rate may
have been more easily controlled. In contrast, invoking such
measures after 2008 may have had little to no effect in altering the
rate of Ceftazidime-resistance going forward.
Table 1. Actual and predicted Ceftazidime-resistance rates
between 1996,2009 in China.
Year At D-R Lower Upper GM(1,1)
1996 5.71 - - - -
1997 13.08 - - - -
1998 11.07 - - - -
1999 12.75 - - - -
2000 16.00 14.19 12.28 16.12 11.96
2001 15.29 18.11 17.77 18.44 16.27
2002 19.07 15.87 15.14 16.60 16.75
2003 24.78 21.57 20.38 22.77 19.92
2004 27.51 29.04 27.42 30.67 25.78
2005 26.84 31.02 30.19 31.85 30.53
2006 25.06 27.82 25.00 30.65 32.31
2007 23.39 24.17 21.60 26.75 31.98
2008 31.66 21.87 19.79 23.95 30.74
2009 50.24 36.33 28.24 43.74 33.79
At=actual drug resistance rate; D-R=calculated rates using the D-R model;
Lower=lower limits of the D-R model; Upper=upper limits of the D-R model;
GM(1,1)=calculated rates using the GM(1,1). No data is designated by ‘‘-’’.
doi:10.1371/journal.pone.0027295.t001
Table 2. Calculated values for RSE, MAD and MAE from rate
curves generated with the D-R and GM(1,1) models.
Model RSE MAD MAE
D-R 6.23 4.40 0.15
GM(1,1) 7.15 5.08 0.18
Calculated values were based on the actual Ceftazidime-resistance rates
between 1996–2009 in China.
doi:10.1371/journal.pone.0027295.t002
Table 3. D-R generated Ceftazidime-resistance rates
beginning with years 1999, 2001, 2005, and 2009.
Year At 1999Ft(R%) 2001Ft(R%) 2005Ft(R%) 2009Ft(R%)
1996 5.71
1997 13.08
1998 11.07 ____
1999 12.75 10.73 10.73 12.38 12.38
2000 16.00 10.96 14.19 14.19 14.19
2001 15.29 10.76 18.11 18.11 18.11
2002 19.07 10.66 15.87 15.87 15.87
2003 24.78 10.58 16.45 21.57 21.57
2004 27.51 10.48 16.86 29.04 29.04
2005 26.84 10.38 17.31 31.02 31.02
2006 25.06 10.29 17.76 27.82 27.82
2007 23.39 10.20 18.19 24.17 24.17
2008 31.66 10.12 18.61 21.87 21.87
2009 50.24 10.03 19.03 20.34 36.33
2010 9.95 19.44 18.84 63.20
2011 9.86 19.84 17.37 76.56
2012 9.78 20.23 15.93 90.08
At=actual drug resistance rate; 1999 Ft(R%)=predicted infection rates
between 1999–2012 based on the actual data from 1996–1998;
2001Ft(R%)=predicted infection rates between 2001–2012 based on the actual
data from 1996–2000; 2005Ft(R%)=predicted infection rates between 2005–
2012 based on the actual data from 1996–2004; 2009Ft(R%)=predicted
infection rates between 2009–2012 based on the actual data from 1996–2008.
The numbers above the underlined values were calculated and fitted to the
model; the numbers below the underlined values were predicted based upon
each fitted curve.
doi:10.1371/journal.pone.0027295.t003
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needed to decrease the spread and occurrence of drug-resistant
bacteria. Our results showed that in 2009, the rate of reported
drug-resistance cases exceeded 30%. In the absence of any
material change in treatment, we estimate that in 2010, the rate
will exceed 60% implying that combination drug therapy should
be reinforced. Furthermore, if the current trends are not altered by
a change in treatment regiments, we anticipate that by 2011, the
rate could exceed 75%. The statistical data on the rate of
appearance of Ceftazidime-resistant E. coli was 50.24% in 2009.
This is consistent with our predictive results indicating the utility of
D-R model in this analysis.
In this study, we simulated the currently available data on drug-
resistance rates of E. coli using D-R and GM(1,1) models. The
Ceftazidime-resistant E. coli data from 1996–2009 in China were
subjected to trend x
2 test, and the results showed that Ceftazidime-
resistance increased annually where the reported rate reached
30% and 50% in 2008 and 2009, respectively. The caveat to this
study as well as any that are based on preexisting data, is that it is
predicated only upon reports of patients who sought medical help
and were treated without response. It is difficult to account for
those who did not seek medical attention, or the many that were
treated with predictable results and thus never reported. Clearly,
more extensive epidemiological studies are necessary to confirm
the findings reported in this paper. Nonetheless, our data show
with incontrovertible evidence that the trend in resistance
experienced a dramatic inflection point to the upside in 2008
and that this trend was predicted by the D-R model. With this in
mind, we must now pay particular attention to the precautionary
limits set by the Ministry of Health (MOH) of the People’ Republic
of China. The regulations defined by the MOH state: 1) when
drug resistance to a target bacterium is over 30%, early warning
information should be reported to all medical personnel; 2) when
resistance exceeds 40%, the drug should be used cautiously and
empirically; 3) if resistance climbs above 50%, use of the drug
should be first verified with a drug sensitivity test and; 4) when
resistance exceeds 75%, use of the drug should be stopped and
reintroduction should be based upon large scale surveillance
studies demonstrating a reduction in the drug resistant pheno-
type to manageable levels (http://www.moh.gov.cn/publicfiles/
business/htmlfiles/mohyzs/s3585/200903/39723.htm). To this
end, we highly recommend that with the increase in the rate of
infection observed herein, more extensive surveillance studies be
conducted to monitor resistance in the Chinese population before
it reaches unmanageable levels.
As with any forecast model under development, there are
caveats. Under- and over- estimation of future trends is by and
large the biggest hurdle. For this reason, the D-R model was
designed to provide upper and lower limits to the forecasted trend
line. In both the H1N1 study [8] and the evaluation of
Ceftazidime-resistant E. coli presented here, the upper and lower
limits to the trend line were never breached suggesting that such
limits are important in encompassing variables that could affect
forecasting future changes.
In conclusion, we used the most up-to-date data on the rate of
Ceftazidime-resistance in E. coli in China to calculate future rate
changes using the new D-R model and the classic GM(1,1) model.
Our results showed that during a period of time when resistance
exhibited a slow but increasing trend as in most early periods of
resistance modeling, both algorithms were equally effective in their
abilities to predict future rate changes. However, when strong
inflection points occurred as observed in 2008, the (GM)1,1 model
was unable to adequately mirror the actual rates that followed
whereas, the D-R model more accurately accounted for these
rapid bursts in resistance.
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